Dolutegravir (GSK1349572) - CAS 1051375-16-6
Catalog number: B0084-438457
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H19F2N3O5
Molecular Weight:
419.38
COA:
Inquire
Targets:
HIV
Description:
Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM, modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-438457 25 mg $298 In stock
Bulk Inquiry
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
S/GSK1349572
MSDS:
Inquire
1.Dolutegravir: an exciting new kid on the block.
Blanco Arévalo JL1, Whitlock GG. Expert Opin Pharmacother. 2014 Mar;15(4):573-82. doi: 10.1517/14656566.2014.868883. Epub 2014 Jan 22.
INTRODUCTION: Dolutegravir is the first second-generation integrase inhibitor approved for the treatment of naïve as well as experienced HIV-infected individuals.
2.Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.
Rathbun RC1, Lockhart SM, Miller MM, Liedtke MD. Ann Pharmacother. 2014 Mar;48(3):395-403. doi: 10.1177/1060028013513558. Epub 2013 Nov 19.
OBJECTIVE: To review the pharmacology, safety, and efficacy of dolutegravir, an integrase strand-transfer inhibitor (INSTI), and to discuss its role in the treatment of HIV-1-infected patients.
3.Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G; SINGLE Investigators. N Engl J Med. 2013 Nov 7;369(19):1807-18. doi: 10.1056/NEJMoa1215541.
BACKGROUND: Dolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was recently approved in the United States for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents. Dolutegravir, in combination with abacavir-lamivudine, may provide a simplified regimen.
4.Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.
Shah BM1, Schafer JJ, Desimone JA Jr. Pharmacotherapy. 2014 May;34(5):506-20. doi: 10.1002/phar.1386. Epub 2013 Dec 18.
The first two integrase strand transfer inhibitors (INSTIs) approved for treatment of patients infected with human immunodeficiency virus (HIV) were raltegravir and elvitegravir. Both raltegravir and elvitegravir are now guideline-preferred agents as part of an antiretroviral regimen for treatment-naive patients. However, raltegravir is dosed twice/day. Elvitegravir is available in a single-tablet regimen and dosed once/day because it is administered with the pharmacokinetic booster cobicistat, a potent CYP3A4 inhibitor that can lead to clinically significant drug-drug interactions. In addition, raltegravir and elvitegravir have a low genetic barrier to resistance and are associated with cross-resistance. Dolutegravir is a new-generation INSTI administered once/day without a pharmacokinetic booster and can be coformulated in a single-tablet regimen. Phase III studies have demonstrated the efficacy and safety of dolutegravir for treatment-naive and treatment-experienced patients.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Products


CAS 431980-38-0 RN-18

RN-18
(CAS: 431980-38-0)

RN-18, a selective inhibitor of virion infectivity factor (Vif) APOBEC interactions and HIV-1 replication (IC50= 6 μM in nonpermissive H9 cells), antagonizes Vi...

CAS 313682-08-5 Brecanavir

Brecanavir
(CAS: 313682-08-5)

Brecanavir is a tyrosyl-based arylsulfonamide, high-affinity, protease inhibitor (PI) for the treatment of human immunodeficiency virus type-1. This compound po...

CAS 1180-71-8 Limonin

Limonin
(CAS: 1180-71-8)

Limonin is a triterpenoid enriched in citrus fruits, which has antivirus and antitumor ability.

CAS 198904-31-3 Atazanavir

Atazanavir
(CAS: 198904-31-3)

Atazanavir is a novel and potent azapeptide protease inhibitor that specifically inhibits the human immunodeficiency virus type 1 (HIV-1) protease enzyme with i...

CAS 144217-65-2 YYA-021

YYA-021
(CAS: 144217-65-2)

YYA-021 enhances the neutralization sensitivity of simian-human immunodeficiency virus (SHIV) carrying the envelope from the clade B clinical human immunodefici...

CAS 154598-52-4 Efavirenz

Efavirenz
(CAS: 154598-52-4)

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of human immunodeficiency virus type 1 (HIV-1) rev...

CAS 136817-59-9 Delavirdine

Delavirdine
(CAS: 136817-59-9)

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of...

CAS 159989-64-7 Nelfinavir

Nelfinavir
(CAS: 159989-64-7)

Nelfinavir is a HIV protease inhibitor; antiretroviral; and anti-tumor agent.

GSK2838232
(CAS: 1443460-91-0)

GSK2838232, a derivative of Betulin, is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection.

CAS 729607-74-3 BMS-707035

BMS-707035
(CAS: 729607-74-3)

BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM.

PNU-104489
(CAS: 177577-60-5)

PNU-104489, a sulfonamidoindol derivative, has been found to be a HIV-1 specific inhibitor and was proved to exhibit activity against BHA-P-resistant HIV-1MF ha...

CAS 871038-72-1 Raltegravir

Raltegravir
(CAS: 871038-72-1)

Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucur...

BMS-488043
(CAS: 452296-83-2)

BMS-488043 is a small-molecule HIV fusion inhibitor.

CAS 150378-17-9 Indinavir

Indinavir
(CAS: 150378-17-9)

Indinavir is a member of the novel hydroxyaminopentane amide class of HIV-1 protease inhibitors. Indinavir is used as an antiviral.

CAS 1416258-16-6 (±)-BI-D

(±)-BI-D
(CAS: 1416258-16-6)

Approximately 2.4–2.9 μM of BI-D was required to inhibit 50% of HIV-Luc infection of WT and Hdgfrp2 KO cells, while the IC50 decreased dramatically, to 160–200 ...

Ingenol 3-Hexanoate
(CAS: 83036-61-7)

Ingenol 3-Hexanoate, an ingenol-derived compound, was more potent in reactivating latent HIV than other known activators such as SAHA, ingenol 3,20-dibenzoate, ...

CAS 157810-81-6 Indinavir sulfate

Indinavir sulfate
(CAS: 157810-81-6)

Indinavir is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV infection and AIDS. It inhibits the HIV-1 protease wi...

CAS 635728-49-3 Darunavir Ethanolate

Darunavir Ethanolate
(CAS: 635728-49-3)

Darunavir Ethanolate is a nonpeptidic HIV protease inhibitor, used to treat HIV infection.

PD 135390
(CAS: 150351-31-8)

PD 135390 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections.

CAS 226700-81-8 Fosamprenavir Calcium Salt

Fosamprenavir Calcium Salt
(CAS: 226700-81-8)

HIV protease inhibitor; water soluble prodrug of amprenavir.

Chemical Structure

CAS 1051375-16-6 Dolutegravir (GSK1349572)

Quick Inquiry

Verification code

Featured Items